Participant Flow Module

Participant Flow Module

The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.

Participant Flow Module path is as follows:

Study -> Results Section -> Participant Flow Module

Participant Flow Module


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:58 AM
NCT ID: NCT03738618
Pre Assignment Details: In total, 666 participants were screened of which 588 participants were randomized. Of the randomized participants, 587 participants were exposed to the investigational medicinal product (IMP): 533 to FE 999049 (Follitropin Delta) and 54 to Placebo. One participant was randomization failure and did not receive the IMP.
Recruitment Details: The trial was performed in 24 investigational sites in 18 states of the United States between Oct 2018 to Dec 2020.
Study: NCT03738618
Study Brief:
Results Section: NCT03738618